OH Cleveland의 방광암 임상 시험
방광암 관련 연구 18개가 Cleveland 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
피험자 모집 중3상
- University Hospitals of Cleveland Case Medical Center ( Site 0834), Cleveland
- Cleveland Clinic - Ohio ( Site 0793), Cleveland
The Vanguard Study: Testing a New Way to Screen for Cancer
피험자 모집 중건강한 지원자 환영
- Louis Stokes Cleveland VA Medical Center, Cleveland
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
피험자 모집 중1상
- University Hospitals Cleveland Medical Center, Cleveland
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
피험자 모집 중2상
- Cleveland Clinic - Oncology Department, Cleveland
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
피험자 모집 중2상
- MetroHealth Medical Center, Cleveland
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
피험자 모집 중3상
- Case Western Reserve University, Cleveland
- Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
- UHHS-Chagrin Highlands Medical Center, Beachwood · 10마일 거리
- 외 2개
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
피험자 모집 중1/2상
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic Foundation, Cleveland
- Cleveland Clinic Taussig Cancer Center Investigational Pharmacy, Cleveland
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
피험자 모집 중1/2상
- Cleveland Clinic Taussig Cancer ( Site 5036), Cleveland
Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy
피험자 모집 중2상
- Cleveland Clinic Taussig Cancer Center, Cleveland
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
피험자 모집 중1상
- University Hospitals Cleveland Medical Center, Cleveland
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
피험자 모집 중관찰 연구
- Cleveland Clinic, Cleveland
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
피험자 모집 중2상
- Cleveland Clinic, Cleveland
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
피험자 모집 중2상
- Cleveland Clinic Main Campus, Cleveland, Cleveland
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
피험자 모집 중2/3상
- Fairview Hospital, Cleveland
- Cleveland Clinic, Cleveland
- Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12마일 거리
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
피험자 모집 중2상
- University Hospitals Cleveland Medical Center, Cleveland
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
피험자 모집 중3상
- Research Site, Cleveland
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- Cleveland Clinic, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
피험자 모집 중관찰 연구
- Massive Bio SYNERGY-AI site, Mayfield Heights · 12마일 거리
다른 도시의 방광암 시험
- New York City, NY연구 36개
- Nashville, TN연구 31개
- Houston, TX연구 31개
- Dallas, TX연구 27개
- Boston, MA연구 26개
- Washington, DC연구 26개
- Los Angeles, CA연구 25개
- Baltimore, MD연구 24개
- Philadelphia, PA연구 23개
- Edison, NJ연구 23개
- St. Louis, MO연구 22개
- Chicago, IL연구 21개
Cleveland의 다른 연구
- 비소세포폐암연구 48개
- 암 (전체)연구 36개
- 유방암연구 33개
- 심부전연구 31개
- 전이성 암연구 30개
- 전립선암연구 30개
- 난소암연구 29개
- 폐암연구 26개
- 대장직장암연구 25개
- 급성 골수성 백혈병연구 20개
- 두경부 편평세포암연구 20개
- 심혈관 질환연구 20개
ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.